A lot of investors may not realise it now but this innovation...

A lot of investors may not realise it now but this innovation combined with DurAVR almost assures us of Breakthrough status (IMHO).

This doesn’t get talked about enough, and the SP certainly doesn’t factor it in as a possibility. If granted, the SP will explode upward - but as is the case most of the time investors will typically react to news after it has happened.

First Criterion: The device provides for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human disease or conditions - tick.

Second Criterion: The device also meets at least one of the following:

1. Represents Breakthrough Technology- tick
2. No Approved or Cleared Alternatives Exist.
3. Offers Significant Advantages over Existing Approved or Cleared Alternatives - tick
4. Device Availability is in the Best Interest of Patients - tick

The DurAVR & ComASUR combo is a prime candidate, and the value of obtaining breakthrough designation is utterly immense - particularly to a suitor who wants to take Marley share from the #1 player.

2021 is going to be an immensely interesting year for AVR. Do your research, know what you hold, ignore the noise, and allow the team to continue the amazing progress made over the last 12-18 months.